Loading…

Bayer announced the opening of a new production facility in Turku, Finland, to increase production capacity of long-acting reversible contraceptives (LARCs). The 250 million euro investment will utilize automation and robotics to create efficiencies and increase capacities.
“The 250 million Euro investment to increase the production capacity of implants and hormonal intrauterine systems (IUS) plays a crucial role in driving Bayer’s global sustainability goal.”bayer.com
Summarized from public sources; check the original articles before acting on it.